Xenon Pharmaceuticals Inc. XENE
$52.48
▼ -0.17% 24H
About
Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and commercializing therapeutics for patients with neurological and psychiatric disorders. The company's lead molecule, azetukalner, is a novel potent selective Kv7 potassium channel opener currently in …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryCanada
Employees316
TickerXENE
Statistics
Market Cap$5.07B
Revenue (TTM)$7.5M
Net Income-$345.9M
Net Margin-4612.1%
EPS$-4.36
P/E-11.94
P/S671.50
P/B7.18
EV/EBITDA-9.45
ROE-37.5%
Dividend Yield—
Price$52.48
Data: Twelve Data · Revenue = mcap / P/S